Socioeconomic disparities in survival after high‐risk neuroblastoma treatment with modern therapy

Socioeconomic disparities in survival after high‐risk neuroblastoma treatment with modern therapy

Background Modern therapeutic advances in high‐risk neuroblastoma have improved overall survival (OS), but it is unclear whether these survival gains have been equitable. This study examined the relationship between socioeconomic status (SES) and overall survival (OS) in children with high‐risk neur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2021-10, Vol.68 (10), p.e29127-n/a
Hauptverfasser: Zheng, Daniel J., Li, Anran, Ma, Clement, Ribeiro, Karina B., Diller, Lisa, Bona, Kira, Marron, Jonathan M.
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Child
Child, Preschool
Children
Cohort Studies
Epidemiology
health care disparities
health services research
Healthcare Disparities
Hematology
Humans
Infant
insurance
Insurance Coverage
Metastases
Neuroblastoma
Neuroblastoma - therapy
Oncology
pediatric oncology
Pediatrics
Population studies
Poverty
Social Class
Socioeconomic Factors
Statistical analysis
Survival
United States - epidemiology
Variables
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Modern therapeutic advances in high‐risk neuroblastoma have improved overall survival (OS), but it is unclear whether these survival gains have been equitable. This study examined the relationship between socioeconomic status (SES) and overall survival (OS) in children with high‐risk neuroblastoma and whether SES‐associated disparities have changed over time. Procedure In this population‐based cohort study, children
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.29127